Frequently Asked Questions
Home / FAQs
For Canadian healthcare professionals only.
Please note: Local policy and the Product Monograph supersede this FAQ. Follow your hospital’s transfusion and emergency haemostasis guidelines.
Laboratory targets and monitoring
Category:
Laboratory targets and monitoring
Clauss fibrinogen is the reference. Where available, ROTEM or TEG may guide both the trigger and the effect of therapy with faster turnaround.
Category:
Laboratory targets and monitoring
For ongoing major bleeding, re-check after the first dose, then at intervals dictated by hemorrhage severity, often every 4 to 6 hours in the first day or at the next viscoelastic cycle.
Category:
Laboratory targets and monitoring
Consider ongoing consumption, dilution, hyperfibrinolysis, laboratory timing relative to infusion, or sampling issues. Reassess dosing and consult hematology.